Icrucumab (Synonyms: Anti-VEGFR1/FLT1 Reference Antibody; IMC-18F1) |
| Catalog No.GC69252 |
Icrucumab (Anti-VEGFR1/FLT1 Reference Antibody; IMC-18F1) is a humanized monoclonal antibody against VEGFR-1 IgG1. Icrucumab has the potential for use in late-stage solid tumor research.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1024603-92-6
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Icrucumab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Icrucumab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *